Literature DB >> 30145177

Diosbulbin B induced G2/M cell cycle arrest in hepatocytes by miRNA-186-3p and miRNA-378a-5p-mediated the decreased expression of CDK1.

Rui Yang1, Mengjuan Wei2, Fan Yang3, Yuchen Sheng4, Lili Ji5.   

Abstract

Diosbulbin B (DB) is the main hepatotoxic compound in Airpotato yam, which is traditionally used for treating thyroid disease and cancer in China, and its hepatotoxic mechanism still remains unclear. This study aims to investigate its hepatotoxic mechanism by focusing on regulating microRNA (miRNA). DB induced hepatotoxicity both in vivo and in vitro. Results of miRNA chip analysis showed that the expression of eleven miRNAs was up-regulated and twelve miRNAs was down-regulated in livers from DB-treated mice. The altered expression of seven miRNAs was further validated by using real-time polymerase chain reaction (RT-PCR) assay. DB induced G2/M arrest in L-02/cytochrome P450 3A4 (CYP3A4) cells in both concentration- and time-dependent manner. A total of eleven predicted target genes was related with cell cycle regulation of those above seven miRNAs, among which the mRNA and protein expression of cyclin-dependent kinase 1 (CDK1) decreased both in vivo and in vitro. Both miR-378a-5p and miR-186-3p have binding sites in the 3'-untranslated region (UTR) of CDK1. With the use of CDK1 3'-UTR luciferase reporter assay, miR-378a-5p and miR-186-3p was found to down-regulate the luciferase activity. The mimics of miR-378a-5p or miR-186-3p reduced CDK1 expression in L-02/CYP3A4 cells, but their inhibitors reversed the decreased CDK1 expression induced by DB. Moreover, overexpression of miR-186-3p inhibitor reversed the G2/M cell cycle arrest induced by DB in L-02/CYP3A4 cells. Taken together, our results showed that DB induced hepatotoxicity by inducing G2/M cell cycle arrest in hepatocytes via miR-186-3p or miR-378a-5p-mediated the reduced CDK1 expression.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  CDK1; Cell Cycle Arrest; DB; Hepatotoxicity; miRNA

Mesh:

Substances:

Year:  2018        PMID: 30145177     DOI: 10.1016/j.taap.2018.08.016

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  7 in total

1.  MicroRNA-186-3p attenuates tumorigenesis of cervical cancer by targeting MCM2.

Authors:  Xiurong Lu; Xiao Song; Xiaohui Hao; Xiaoyu Liu; Xianyu Zhang; Na Yuan; Huan Ma; Zhilin Zhang
Journal:  Oncol Lett       Date:  2021-05-19       Impact factor: 2.967

2.  miR-378a-5p and miR-630 induce lens epithelial cell apoptosis in cataract via suppression of E2F3.

Authors:  Weiwei Gao; Xiaoqing Zhou; Ruihua Lin
Journal:  Braz J Med Biol Res       Date:  2020-04-27       Impact factor: 2.590

3.  Low-dose Diosbulbin-B (DB) activates tumor-intrinsic PD-L1/NLRP3 signaling pathway mediated pyroptotic cell death to increase cisplatin-sensitivity in gastric cancer (GC).

Authors:  Chunfeng Li; Junqiang Qiu; Yingwei Xue
Journal:  Cell Biosci       Date:  2021-02-12       Impact factor: 7.133

4.  Possible Role of Porphyromonas gingivalis in the Regulation of E2F1, CDK11, and iNOS Gene Expression in Neuronal Cell Cycle: A Preliminary Study.

Authors:  Endang W Bachtiar; Tienneke R Septiwidyati
Journal:  J Int Soc Prev Community Dent       Date:  2021-09-21

5.  MiR-186-3p attenuates tumorigenesis of cervical cancer by targeting IGF1.

Authors:  Xiurong Lu; Xiao Song; Xiaohui Hao; Xiaoyu Liu; Xianyu Zhang; Na Yuan; Huan Ma; Zhilin Zhang
Journal:  World J Surg Oncol       Date:  2021-07-12       Impact factor: 2.754

6.  MiR-378a-5p Regulates Proliferation and Migration in Vascular Smooth Muscle Cell by Targeting CDK1.

Authors:  Shaoyan Liu; Yanyan Yang; Shaoyan Jiang; Hong Xu; Ningning Tang; Amara Lobo; Rui Zhang; Song Liu; Tao Yu; Hui Xin
Journal:  Front Genet       Date:  2019-02-19       Impact factor: 4.599

7.  Angelica sinensis polysaccharide (ASP) attenuates diosbulbin-B (DB)-induced hepatotoxicity through activating the MEK/ERK pathway.

Authors:  Chunfeng Li; Shumin Liu; Jian Zheng; Yingwei Xue
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.